DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Integra LifeSciences (NASDAQ: IART)

49.99 0.33 (0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IART $49.99 0.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.70
Previous Close $49.66
Daily Range $48.35 - $50.00
52-Week Range $37.93 - $51.32
Market Cap $1.6B
P/E Ratio -217.35
Dividend (Yield) $0.00 (0.0%)
Volume 91,288
Average Daily Volume 152,974
Current FY EPS $2.96

Sector

Healthcare

Industry

Healthcare Information Services

Integra LifeSciences (IART) Description

The Company is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments. Website: http://www.integralife.com/

News & Commentary

Integra Beats on the Bottom Line

Resistance from payors over spine procedures pressures surgical technology specialist.

InsiderInsights.com Daily Round Up 8/26/14: Aeropostale, AirT, SWK Holdings, Ironclad Performance We

InsiderInsights.com Daily Round Up 8/26/14: Aeropostale, AirT, SWK Holdings, Ironclad Performance Wear

Integra Lifesciences Holdings Corp Stock Upgraded (IART)

Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcrip

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcript

Integra LifeSciences Holdings (IART) Q2 2014 Results - Earnings Call Webcast

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $90

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $900M

Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog

Integra LifeSciences (IART): New Analyst Report from Zacks Equity Research - Zacks Equity Research R

Integra LifeSciences (IART): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Integra Lifesciences Down to Sell - Analyst Blog

Integra Lifesciences Down to Sell - Analyst Blog

Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog

See More IART News...

IART's Top Competitors

IART $49.99 (0.66%)
Current stock: IART
MDT $63.85 (1.16%)
Current stock: MDT
$0.00 (0.00%)
Current stock:
COV $86.83 (0.15%)
Current stock: COV